Fortress Biotech, Inc. (FBIO) earnings
FBIO earnings moved a median of +0.34% by the close. Quarterly and annual FBIO reports and results, each read against the price at its own news timestamp. Back to the FBIO overview →
21 measured FBIO earnings events.
Where these FBIO earnings landedvs 21 measured FBIO earnings reactions
| Middle 50% of FBIO earnings reactions | -3.75% to +2.55% |
|---|---|
| Median reaction (to close) | +0.34% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 FBIO earnings events with a measured close landed between -3.75% and +2.55%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Fortress Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | -5.48% | +0.34% | |
| Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | -5.48% | +0.34% | |
| Form 10-Q Fortress Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.13% | +2.55% | |
| Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | -2.13% | +2.55% | |
| Form 10-K Fortress Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.91% | -10.18% | |
| Form 10-Q Fortress Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.81% | +6.07% | |
| Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +0.81% | +6.07% | |
| Form 10-Q Fortress Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.96% | +4.43% | |
| Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -2.96% | +4.43% | |
| Form 10-Q Fortress Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.22% | +0.56% | |
| Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -2.22% | +0.56% | |
| Form 10-K Fortress Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.04% | -3.75% | |
| Form 10-Q Fortress Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.94% | -7.74% | |
| Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -1.94% | -7.74% | |
| Form 10-Q Fortress Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.65% | -4.23% | |
| Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | +2.65% | -4.23% | |
| Form 10-Q Fortress Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.57% | |
| Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | +0.00% | +0.57% | |
| Form 10-K Fortress Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.42% | -2.93% | |
| Form 10-Q Fortress Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.17% | +0.00% | |
| Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | -2.17% | +0.00% |
Keep exploring
More FBIO: analyst actions → · SEC filings → · FBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Retractable Technologies, Inc. (RVP) | 237 | 0.00% | 45% |
| Assembly Biosciences, Inc. (ASMB) | 236 | -0.01% | 41% |
| Rockwell Medical, Inc. (RMTI) | 235 | +0.40% | 57% |
| Equillium, Inc. (EQ) | 234 | 0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.